Latest Insight into the Relation of Metabolic Syndrome with Thyroid Dysfunction

Dr. Ashfaq ul Hassan; Dr. Shazia Nazir

Authors

Dr. Ashfaq ul Hassan
Dr. Shazia Nazir

Keywords:

thyroid, hyperthyroidism, hypothyroidism, subclinical, lipoprotein TRH (thyroid releasing hormone), TSH (thyroid stimulating hormone)

Abstract

The Metabolic syndrome is a modern epidemic and is considrred to be one of the major public health issues of this century. It is constellation of physical conditions and metabolic abnormalities commonly found in association with increased risk for development of Type II diabetes mellitus, cardiovascular disease and other medical conditions. Thyroid hormones play an important role in regulating energy homeostasis. In addition, thyroid hormones can regulate lipoprotein, glucose metabolism and blood pressure. Thus there is possibility of thyroid dysfunction (may be cause or effect) having an association with metabolic syndrome and its component. The study was aimed to find out occurrence of metabolic syndrome in hypothyroid patients and to determine the association between the components of metabolic syndrome and thyroid hypofunction.

Downloads

How to Cite

Latest Insight into the Relation of Metabolic Syndrome with Thyroid Dysfunction. (2015). Global Journal of Medical Research, 15(F3), 5-12. https://medicalresearchjournal.org/index.php/GJMR/article/view/952

Download Citation

References

Liselle Douyon, David Schteingart (2002) Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. 31(1), 173-189.

H Adsani, L Hoffer (1997) Resting energy expenditure is sensitive to small dose change in patients with chronic thyroid hormone replacement. 92, 118-125.

Enza Fommei, Giorgio Iervasi (2002) The Role of Thyroid Hormone in Blood Pressure Homeostasis: Evidence from Short-Term Hypothyroidism in Humans. 87(5), 1996-2000.

Ja- Franklin (1994) The management of hyperthyroidism. 330, 19-44.

C Wang, L Crapo (1997) The epidemiology of thyroid disease and implications for screening. 26, 189-218.

M Bauer, P Whybrow (1986) The effect of changing thyroid function on cyclic effective illness in human subjects. 143, 633-636.

Mehran Massoudi, Elaine Meilahn, Trevor Orchard, Thomas Foley, Lewis Kuller, Joseph Costantino, Alhaji Buhari (1995) Prevalence of thyroid antibodies among healthy middle-aged women. 5(3), 229-233.

Shigeki Sakata, Masafumi Matsuda, Toru Ogawa, Hiroshi Takuno, Ikuo Matsul, Hiroshi Sarui, Keigo Yasuda (1994) Prevalence of thyroid hormone autoantibodies in healthy subjects. 41(3), 365-370.

M Mcdermott, E Ridgway (2001) Subclinical hypothyroidism is mild thyroid failure and should be treated. 86, 4585-4590.

Martin Surks, Enrico Ocampo (1996) Subclinical thyroid disease. 100(2), 217-223.

Goswami B, V Gupta, V Mallika (2008) Evaluation of lipid profile in hypothyroid patients. Our experience. 5, 43-47.

S Razvi, L Ingoe, G Keeka, C Oates, C Mcmillan, J Weaver (2007) The beneficial effect of L-thyroxin on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. 92, 1715-1723.

D Cooper (2001) Subclinical hypothyroidism. 345(4), 260-265.

J Hollowell, N Staehling, W Flanders (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). 87, 489-499.

V Fatourechi (2004) Subclinical hypothyroidism: when to treat, when to watch. 44, 533-539.

M Surks, J Hollowell (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. 92, 4575-4582.

James Chu, Lawrence Crapo (2001) The Treatment of Subclinical Hypothyroidism Is Seldom Necessary. 86(10), 4591-4599.

V Fatourechi, G Klee, S Grebe (2003) Effects of reducing the upper limit of normal TSH values [letter. 290(24), 3195-3196.